Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.
2.

[TH1 response in the experimental infection with Trypanosoma cruzi].

Cardoni RL, Antúnez MI, Abrami AA.

Medicina (B Aires). 1999;59 Suppl 2:84-90. Spanish.

PMID:
10668248
3.

Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Silverio JC, de-Oliveira-Pinto LM, da Silva AA, de Oliveira GM, Lannes-Vieira J.

Int J Exp Pathol. 2010 Feb;91(1):72-86. doi: 10.1111/j.1365-2613.2009.00670.x. Epub 2009 Oct 28.

4.
5.

Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.

Carvalho CM, Silverio JC, da Silva AA, Pereira IR, Coelho JM, Britto CC, Moreira OC, Marchevsky RS, Xavier SS, Gazzinelli RT, da Glória Bonecini-Almeida M, Lannes-Vieira J.

PLoS Negl Trop Dis. 2012;6(5):e1644. doi: 10.1371/journal.pntd.0001644. Epub 2012 May 8.

6.

Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.

Reyes JL, Terrazas LI, Espinoza B, Cruz-Robles D, Soto V, Rivera-Montoya I, Gómez-García L, Snider H, Satoskar AR, Rodríguez-Sosa M.

Infect Immun. 2006 Jun;74(6):3170-9.

7.

IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.

van Den Broek M, Bachmann MF, Köhler G, Barner M, Escher R, Zinkernagel R, Kopf M.

J Immunol. 2000 Jan 1;164(1):371-8.

8.

IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.

Marinho CR, Nuñez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM.

Scand J Immunol. 2007 Aug-Sep;66(2-3):297-308.

9.

Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain).

Chandra M, Tanowitz HB, Petkova SB, Huang H, Weiss LM, Wittner M, Factor SM, Shtutin V, Jelicks LA, Chan J, Shirani J.

Int J Parasitol. 2002 Jun 15;32(7):897-905.

PMID:
12062561
10.

Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.

Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS.

Circulation. 2000 Dec 12;102(24):3003-8.

11.
12.

Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi.

Michailowsky V, Celes MR, Marino AP, Silva AA, Vieira LQ, Rossi MA, Gazzinelli RT, Lannes-Vieira J, Silva JS.

J Immunol. 2004 Jul 1;173(1):463-70.

13.

Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure.

Romanha AJ, Alves RO, Murta SM, Silva JS, Ropert C, Gazzinelli RT.

J Infect Dis. 2002 Sep 15;186(6):823-8. Epub 2002 Aug 16.

14.
15.

Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi.

Talvani A, Ribeiro CS, Aliberti JC, Michailowsky V, Santos PV, Murta SM, Romanha AJ, Almeida IC, Farber J, Lannes-Vieira J, Silva JS, Gazzinelli RT.

Microbes Infect. 2000 Jul;2(8):851-66.

PMID:
10962268
16.

Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection.

Esper L, Utsch L, Soriani FM, Brant F, Esteves Arantes RM, Campos CF, Pinho V, Souza DG, Teixeira MM, Tanowitz HB, Vieira LQ, Machado FS.

Microbes Infect. 2014 Jun;16(6):481-90. doi: 10.1016/j.micinf.2014.03.007. Epub 2014 Apr 1.

PMID:
24704475
18.

Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice.

Graefe SE, Jacobs T, Gaworski I, Klauenberg U, Steeg C, Fleischer B.

Microbes Infect. 2003 Aug;5(10):833-9.

PMID:
12919851
19.

Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma.

Simmons CP, Goncalves NS, Ghaem-Maghami M, Bajaj-Elliott M, Clare S, Neves B, Frankel G, Dougan G, MacDonald TT.

J Immunol. 2002 Feb 15;168(4):1804-12.

20.

Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi.

Abrahamsohn IA, da Silva AP, Coffman RL.

Infect Immun. 2000 Apr;68(4):1975-9.

Items per page

Supplemental Content

Write to the Help Desk